Drug-Associated Lymphoma and Pseudolymphoma: Recognition and Management

Dermatologic Clinics

Volumn 25, Issue 2, 2007, Pages 233-244

  Albrecht, Joerg ^a   Fine, Lauren Ann ^a   Piette, Warren ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; ANTIRHEUMATIC AGENT; ANTITHYROID AGENT; CARBAMAZEPINE; CEFIXIME; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROQUINONE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; PENICILLIN G; PHENOBARBITAL; PHENYTOIN; SEDATIVE AGENT; SEX HORMONE; SULFONAMIDE; UNINDEXED DRUG; VACCINE; VALPROIC ACID;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE MANAGEMENT; DOSE RESPONSE; FEVER; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY REACTION; MYCOSIS FUNGOIDES; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOLYMPHOMA; REVIEW; SKIN LYMPHOMA;

DRUG ERUPTIONS; HUMANS; LYMPHOMA; PSEUDOLYMPHOMA;

EID: 34147184702     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.01.008     Document Type: Review

References (81)

1. Kaudewitz P. Pseudolymphomas of the skin (Pseudolymphome der Haut). In: Braun-Falko O., Plewig G., and Wolff H.H. (Eds). Dermatology and venerology (Dermatologie und Venerologie) (1996), Springer, Berlin 1390-1396
2. Bocquet H., Bagot M., and Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15 4 (1996) 250-257
3. Peyrière H., Dereure O., Breton H., et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 155 2 (2006) 422-428
4. Callot V., Roujeau J.C., Bagot M., et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol 132 11 (1996) 1315-1321
5. Sontheimer R.D., and Houpt K.R. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 134 7 (1998) 874-876
6. Bonnetblanc J.M. Drug hypersensitivity syndrome. Dermatology 187 2 (1993) 84-85
7. Hicks R.A., Murphy J.V., and Jackson M.A. Kawasaki-like syndrome caused by carbamazepine. Pediatr Infect Dis J 7 7 (1988) 525-526
8. Sullivan J.R., and Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis?. Arch Dermatol 137 3 (2001) 357-364
9. Jacobs D.S. Primary gastic malignant lymphoma and pseudolymphoma. Am J Clin Pathol 40 (1963) 379-394
10. Ploysangam T., Breneman D.L., and Mutasim D.F. Cutaneous pseudolymphomas. J Am Acad Dermatol 38 6 Pt 1 (1998) 877-895
11. Goel A., and Walia R.L. Pseudolymphoma revisited. Indian J Dermatol Venereol Leprol 70 (2004) 48-51
12. Salzstein S.L., and Ackerman L.V. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphoma. Cancer 12 (1959) 164-182
13. Anthony J.J. Malignant lymphoma associated with hydantoin drugs. Arch Neurol 22 5 (1970) 450-454
14. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 19 (1994) 1272-1285
15. Nolden S., Casper C., Kuhn A., et al. Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate. Mult Scler 11 2 (2005) 245-248
16. Mutasim D.F. Lymphomatoid drug eruption mimicking digitate dermatosis: cross reactivity between two drugs that suppress angiotensin II function. Am J Dermatopathol 25 4 (2003) 331-334
17. Luelmo A.J., Mieras B.C., Martin-Urda M.T., et al. Generalized cutaneous B-cell pseudolymphoma induced by neuroleptics. Arch Dermatol 128 1 (1992) 121-123
18. Hyman G.A., and Sommers S.C. The development of Hodgkin's disease and lymphoma during anticonvulsant therapy. Blood 28 3 (1966) 416-427
19. Hodak E., Phenig E., Amichai B., et al. Unilesional mycosis fungoides: a study of seven cases. Dermatology 201 4 (2000) 300-306
20. Citarella L., Massone C., Kerl H., et al. Lichen sclerosus with histopathologic features simulating early mycosis fungoides. Am J Dermatopathol 25 6 (2003) 463-465
21. Crowson A.N., Magro C.M., and Zahorchak R. Atypical pigmentary purpura: a clinical, histopathologic, and genotypic study. Hum Pathol 30 9 (1999) 1004-1012
22. Rijlaarsdam J.U., and Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol 13 3 (1994) 187-196
23. Cerroni L., and Goteri G. Differential diagnosis between cutaneous lymphoma and pseudolymphoma. Anal Quant Cytol Histol 25 4 (2003) 191-198
24. Flaig M.J., Cerroni L., Schuhmann K., et al. Follicular mycosis fungoides. A histopathologic analysis of nine cases. J Cutan Pathol 28 10 (2001) 525-530
25. Holm N., Flaig M.J., Yazdi A.S., et al. The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol 29 8 (2002) 447-452
26. Michie S.A., Abel E.A., Hoppe R.T., et al. Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. J Invest Dermatol 93 1 (1989) 116-120
27. Wood G.S., Tung R.M., Haeffner A.C., et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 103 1 (1994) 34-41
28. Choi T.S., Doh K.S., Kim S.H., et al. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol 148 4 (2003) 730-736
29. Magro C.M., Crowson A.N., Kovatich A.J., et al. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol 34 2 (2003) 119-129
30. Delaporte E., Catteau B., Cardon T., et al. [Cutaneous pseudolymphoma during treatment of rheumatoid polyarthritis with low-dose methotrexate]. Ann Dermatol Venereol 122 8 (1995) 521-525 [in French]
31. Kardaun S.H., Scheffer E., and Vermeer B.J. Drug-induced pseudolymphomatous skin reactions. Br J Dermatol 118 4 (1988) 545-552
32. Wolf R., Kahane E., and Sandbank M. Mycosis fungoides-like lesions associated with phenytoin therapy. Arch Dermatol 121 9 (1985) 1181-1182
33. Gams R.A., Neal J.A., and Conrad F.G. Hydantoin-induced pseudo-pseudolymphoma. Ann Intern Med 69 3 (1968) 557-568
34. D'Incan M., Souteyrand P., Bignon Y.J., et al. Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sezary syndrome. Arch Dermatol 128 10 (1992) 1371-1374
35. Kulow B.F., Cualing H., Steele P., et al. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma. J Cutan Med Surg 6 6 (2002) 519-528
36. Harris D.W., Ostlere L., Buckley C., et al. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol 127 4 (1992) 403-406
37. Kleier R.S., Breneman D.L., and Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol 127 9 (1991) 1361-1364
38. Magro C.M., and Crowson A.N. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Hum Pathol 27 2 (1996) 125-132
39. Ghislain P.D., and Roujeau J.C. Treatment of severe drug reactions: Steven-Johnsons syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 8 1 (2002) 5
40. Houwerzijl J., De Gast G.C., Nater J.P., et al. Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity. Clin Exp Immunol 29 2 (1977) 272-277
41. Antunes A., Davril A., Trechot P., et al. [Minocycline hypersensitivity syndrome]. Ann Dermatol Venereol 126 6-7 (1999) 518-521 [in French]
42. Braun R.P., French L.E., Feldmann R., et al. Cutaneous pseudolymphoma, lymphomatoid contact dermatitis type, as an unusual cause of symmetrical upper eyelid nodules. Br J Dermatol 143 2 (2000) 411-414
43. De Vriese A.S., Philippe J., Van Renterghem D.M., et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore) 74 3 (1995) 144-151
44. Spielberg S.P., Gordon G.B., Blake D.A., et al. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med 305 13 (1981) 722-727
45. Shear N.H., and Spielberg S.P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82 6 (1988) 1826-1832
46. Nathan D.L., and Belsito D.V. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol 38 5 Pt 2 (1998) 806-809
47. Wong I.C., Mawer G.E., and Sander J.W. Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother 33 10 (1999) 1037-1042
48. Descamps V., Valance A., Edlinger C., et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 137 3 (2001) 301-304
49. Ichiche M., Kiesch N., and De Bels D. DRESS syndrome associated with HHV-6 reactivation. Eur J Intern Med 14 8 (2003) 498-500
50. Debarbieux S., Deroo-Berger M.C., Grande S., et al. [Drug hypersensitivity syndrome associated with a primary HHV6 infection]. Ann Dermatol Venereol 133 2 (2006) 145-147 [in French]
51. Beller T.C., and Boyce J.A. Prolonged anticonvulsant hypersensitivity syndrome related to lamotrigine in a patient with human immunodeficiency virus. Allergy Asthma Proc 23 6 (2002) 415-419
52. Masruha M.R., Marques C.M., Vilanova L.C., et al. Drug induced pseudolymphoma secondary to ethosuximide. J Neurol Neurosurg Psychiatr 76 11 (2005) 1610
53. Melzer M., Keane F.M., Eykyn S.J., et al. A pseudolymphomatous skin reaction secondary to flucloxacillin. J Infect 40 2 (2000) 198-199
54. Jabbar A., and Siddique T. A case of pseudolymphoma leukaemia syndrome following cefixime. Br J Haematol 101 1 (1998) 209
55. Frouin E., Roth B., Grange A., et al. [Hypersensitivity to fluindione (Previscan). Positive skin patch tests]. Ann Dermatol Venereol 132 12 Pt 1 (2005) 1000-1002 [in French]
56. Milionis H.J., Skopelitou A., and Elisaf M.S. Hypersensitivity syndrome caused by amitriptyline administration. Postgrad Med J 76 896 (2000) 361-363
57. Shelley W.B., and Shelley E.D. Pseudolymphoma at site of clonidine patch. Lancet 350 9086 (1997) 1223-1224
58. Wilkin J.K., Hammond J.J., and Kirkendall W.M. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol 116 8 (1980) 902-905
59. Furness P.N., Goodfield M.J., MacLennan K.A., et al. Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides. J Clin Pathol 39 8 (1986) 902-907
60. Viraben R., Lamant L., and Brousset P. Losartan-associated atypical cutaneous lymphoid hyperplasia. Lancet 350 9088 (1997) 1366
61. Henderson C.A., and Shamy H.K. Atenolol-induced pseudolymphoma. Clin Exp Dermatol 15 2 (1990) 119-120
62. Blazejak T., and Holzle E. [Phenothiazine-induced pseudolymphoma]. Hautarzt 41 3 (1990) 161-163 [in German]
63. Raymond J.Z., and Goldman H.M. An unusual cutaneous reaction secondary to allopurinol. Cutis 41 5 (1988) 323-326
64. Kim K.J., Lee M.W., Choi J.H., et al. CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture. Br J Dermatol 146 5 (2002) 882-884
65. Kalimo K., Rasanen L., Aho H., et al. Persistent cutaneous pseudolymphoma after intradermal gold injection. J Cutan Pathol 23 4 (1996) 328-334
66. Michel F., Navellou J.C., Ferraud D., et al. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine 72 1 (2005) 82-85
67. Teo L., and Tan E. Sulphasalazine-induced DRESS. Singapore Med J 47 3 (2006) 237-239
68. Bourezane Y., Salard D., Hoen B., et al. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy. Clin Infect Dis 27 5 (1998) 1321-1322
69. Ozaki N., Miura Y., Sakakibara A., et al. A case of hypersensitivity syndrome induced by methimazole for Graves' disease. Thyroid 15 12 (2005) 1333-1336
70. Moseley A.C., Lindsley H.B., Skikne B.S., et al. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease. J Rheumatol 27 3 (2000) 810-813
71. Clark S.H., Duvic M., and Prieto V.G. Mycosis fungoides-like reaction in a patient treated with Gleevec. J Cutan Pathol 30 4 (2003) 279-281
72. Lee M.W., Choi J.H., Sung K.J., et al. A case of cutaneous pseudolymphoma associated with silicone injection. Acta Derm Venereol 84 4 (2004) 312-313
73. Dar N.R., Shaheen, Mustafvi S.A., et al. Cutaneous pseudolymphoma due to topical application of 4% hydroquinone cream for melasma. J Coll Physicians Surg Pak 15 8 (2005) 496-497
74. Maubec E., Pinquier L., Viguier M., et al. Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol 52 4 (2005) 623-629
75. Stavrianeas N.G., Katoulis A.C., Kanelleas A., et al. Papulonodular lichenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination. Dermatology 205 2 (2002) 166-168
76. Knowles S.R., Shapiro L.E., and Shear N.H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 21 6 (1999) 489-501
77. Bigby M., Jick S., Jick H., et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 256 24 (1986) 3358-3363
78. Knowles S.R., Shapiro L.E., and Shear N.H. Reactive metabolites and adverse drug reactions: clinical considerations. Clin Rev Allergy Immunol 24 3 (2003) 229-238
79. Tennis P., and Stern R.S. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 49 2 (1997) 542-546
80. Gennis M.A., Vemuri R., Burns E.A., et al. Familial occurrence of hypersensitivity to phenytoin. Am J Med 91 6 (1991) 631-634
81. Rekhtman D., and Eisenstein E.M. Glucocorticoid treatment of severe pediatric drug hypersensitivity syndrome. Pediatr Asthma Allerdgy Immunol 18 3 (2005) 156-160